These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1060357)

  • 1. Oral treatment of menopausal symptoms with natural oestrogens. Experiences with a new series of oestrogens and oestrogen-gestagen combinations.
    Borglin NE; Staland B
    Acta Obstet Gynecol Scand Suppl; 1975; 43():1-11. PubMed ID: 1060357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
    Staland B
    Maturitas; 1981 Aug; 3(2):145-56. PubMed ID: 7026979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
    Strandberg TE; Ylikorkala O; Tikkanen MJ
    Am J Cardiol; 2003 Jul; 92(2):212-4. PubMed ID: 12860228
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
    Christiansen C; Christensen MS; Grande P; Transbøl I
    Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
    Jensen J; Christiansen C
    Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisequens.
    Drug Ther Bull; 1981 Jul; 19(16):63-4. PubMed ID: 7274066
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A; Christiansen C; Transbøl I
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women.
    Hagen C; Christiansen C; Christensen MS; Transbøl I
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):486-91. PubMed ID: 6812338
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
    Staland B
    Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kliogest--the possibility of hormonal substitution in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
    Fraser DI; Parsons A; Whitehead MI; Wordsworth J; Stuart G; Pryse-Davies J
    Fertil Steril; 1990 Mar; 53(3):460-8. PubMed ID: 2407564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
    Aedo AR; Sundén M; Landgren BM; Diczfalusy E
    Maturitas; 1989 Jun; 11(2):159-68. PubMed ID: 2547139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial and vaginal response to three different oestrogen preparations administered by the transdermal and oral routes.
    Johannisson E; Landgren BM; Diczfalusy E
    Maturitas; 1988 Oct; 10(3):181-92. PubMed ID: 3185292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women.
    Jespersen CM; Arnung K; Hagen C; Hilden T; Nielsen F; Nielsen MD; Giese J
    J Hypertens; 1983 Dec; 1(4):361-4. PubMed ID: 6442719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.